Kalikaki, Aristea <br/><br/>
DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.  [electronic resource] 

 -  Clinical lung cancer  Mar 2009 
 - 118-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-7304 
<br/><br/><label>Standard No.: </label>10.3816/CLC.2009.n.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adenocarcinoma, Bronchiolo-Alveolar--drug therapy<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>DNA Repair--genetics<br/>DNA-Binding Proteins--genetics<br/>Endonucleases--genetics<br/>Female<br/>Genotype<br/>Glutathione S-Transferase pi--genetics<br/>Glutathione Transferase--genetics<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Organoplatinum Compounds--therapeutic use<br/>Polymerase Chain Reaction<br/>Polymorphism, Genetic--genetics<br/>Polymorphism, Restriction Fragment Length<br/>Prognosis<br/>Retrospective Studies<br/>Survival Rate<br/>Treatment Outcome<br/>X-ray Repair Cross Complementing Protein 1<br/>Xeroderma Pigmentosum Group D Protein--genetics